Results 91 to 100 of about 56,249 (222)
Introduction The V-GOOD study evaluated the effectiveness of trimetazidine modified-release (MR) 80 mg once daily (OD) in patients with chronic coronary syndrome (CCS) who remained symptomatic despite antianginal therapies in routine clinical practice ...
Luís Henrique Wolff Gowdak +17 more
doaj +1 more source
ABSTRACT Background Cardiovascular disease (CVD) risk assessment based on single‐time‐point measurements may inadequately capture the dynamic interplay of obesity, metabolic dysfunction, and chronic inflammation. Understanding their long‐term co‐evolution may improve CVD risk stratification.
Qinggao Wang +4 more
wiley +1 more source
Dynamics of proinflammatory cytokines level in stable angina (II–III functional class)
The article discusses the evaluation of cytokine level (IL-1β, IL-6) in patients with II–III functional class stable angina. In the group of patients with II–III class stable angina, the standard therapy failed to normalize the level of proinflammatory ...
E. K. Gordeeva, A. H. Kade, S. A. Zanin
doaj
In cardiovascular disease (CVD) patients, accelerated biological aging is independently associated with elevated mortality risk, which is mediated by neurodegenerative disease. Early‐onset CVD amplifies the mortality risk, whereas a healthy lifestyle confers partial protection.
Jinyue Li, Han Ma, Guohua Wang
wiley +1 more source
ABSTRACT Background and Aims The associations of two‐point change patterns of low‐density lipoprotein cholesterol (LDL‐C) and high‐sensitivity C‐reactive protein (hs‐CRP) with major adverse cardiovascular events (MACE) remain underexplored, particularly in Chinese populations.
Jiayin Guo +5 more
wiley +1 more source
ABSTRACT Objective This pilot study aimed to explore the association between the GRACE score and right ventricular (RV) function, including ejection fraction, volumes, and stroke volume, assessed using three‐dimensional echocardiography in patients with acute inferior STEMI undergoing primary PCI.
Hedieh Alimi +4 more
wiley +1 more source
CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
Aim. To investigate effectiveness and safety of trimetazidine MB in the complex treatment of stable angina. In total, 90 patients were examined – 57 women and 33 men aged 48-70 years (mean age 61,4 ± 6,03 years).
N. A. Shostak +5 more
doaj
ABSTRACT Background Ischemic heart disease (IHD) remains a leading cause of mortality and disability worldwide. Using Global Burden of Disease (GBD) 2021 estimates, this study provides an integrated assessment of IHD burden across the Middle East and North Africa (MENA) region from 1990 to 2021, highlighting temporal trends, inter‐country heterogeneity,
Nahid Karamzad +7 more
wiley +1 more source
The Therapeutic Potential of H2S‐Releasing Platforms in Cardiovascular Applications
The Therapeutic Potential of H2S‐Releasing Platforms. ABSTRACT Once known as a toxic gas, hydrogen sulfide (H2S) is now making its way into many therapeutic applications. Similar to its other fellow endogenous gasotransmitters, nitric oxide and carbon monoxide, H2S is a small gas with a short half‐life, making it extremely capable of penetrating ...
Tia N. Shorter, Elizabeth J. Brisbois
wiley +1 more source
Hsa_circ_0044097 expression level was decreased AS patients and in ox‐LDL‐HASMC. The expression level of hsa_circ_0044097 is negatively correlated with the levels of hs‐CRP and LDL‐C. Hsa_circ_0044097 can be a biomarker for the diagnosis and prediction of MACE.
Cencen Ren, Yungen Jiao
wiley +1 more source

